Cargando…

Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study

BACKGROUND: End-stage renal disease (ESRD) is associated with uremia and increased systemic inflammation. Alteration of the intestinal microbiota may facilitate translocation of endotoxins into the systemic circulation leading to inflammation. We hypothesized that children with ESRD have an altered...

Descripción completa

Detalles Bibliográficos
Autores principales: Crespo-Salgado, Janice, Vehaskari, V. Matti, Stewart, Tyrus, Ferris, Michael, Zhang, Qiang, Wang, Guangdi, Blanchard, Eugene E., Taylor, Christopher M., Kallash, Mahmoud, Greenbaum, Larry A., Aviles, Diego H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027112/
https://www.ncbi.nlm.nih.gov/pubmed/27640125
http://dx.doi.org/10.1186/s40168-016-0195-9
_version_ 1782454187960827904
author Crespo-Salgado, Janice
Vehaskari, V. Matti
Stewart, Tyrus
Ferris, Michael
Zhang, Qiang
Wang, Guangdi
Blanchard, Eugene E.
Taylor, Christopher M.
Kallash, Mahmoud
Greenbaum, Larry A.
Aviles, Diego H.
author_facet Crespo-Salgado, Janice
Vehaskari, V. Matti
Stewart, Tyrus
Ferris, Michael
Zhang, Qiang
Wang, Guangdi
Blanchard, Eugene E.
Taylor, Christopher M.
Kallash, Mahmoud
Greenbaum, Larry A.
Aviles, Diego H.
author_sort Crespo-Salgado, Janice
collection PubMed
description BACKGROUND: End-stage renal disease (ESRD) is associated with uremia and increased systemic inflammation. Alteration of the intestinal microbiota may facilitate translocation of endotoxins into the systemic circulation leading to inflammation. We hypothesized that children with ESRD have an altered intestinal microbiota and increased serum levels of bacterially derived uremic toxins. METHODS: Four groups of subjects were recruited: peritoneal dialysis (PD), hemodialysis (HD), post-kidney transplant and healthy controls. Stool bacterial composition was assessed by pyrosequencing analysis of 16S rRNA genes. Serum levels of C-reactive protein (CRP), D-lactate, p-cresyl sulfate and indoxyl sulfate were measured. RESULTS: Compared to controls, the relative abundance of Firmicutes (P = 0.0228) and Actinobacteria (P = 0.0040) was decreased in PD patients. The relative abundance of Bacteroidetes was increased in HD patients (P = 0.0462). Compared to HD patients the relative abundance of Proteobacteria (P = 0.0233) was increased in PD patients. At the family level, Enterobacteriaceae was significantly increased in PD patients (P = 0.0020) compared to controls; whereas, Bifidobacteria showed a significant decrease in PD and transplant patients (P = 0.0020) compared to control. Alpha diversity was decreased in PD patients and kidney transplant using both phylogenetic and non-phylogenetic diversity measures (P = 0.0031 and 0.0003, respectively), while beta diversity showed significant separation (R statistic = 0.2656, P = 0.010) between PD patients and controls. ESRD patients had increased serum levels of p-cresyl sulfate and indoxyl sulfate (P < 0.0001 and P < 0.0001, respectively). The data suggests that no significant correlation exists between the alpha diversity of the intestinal microbiota and CRP, D-lactate, or uremic toxins. Oral iron supplementation results in expansion of the phylum Proteobacteria. CONCLUSIONS: Children with ESRD have altered intestinal microbiota and increased bacterially derived serum uremic toxins.
format Online
Article
Text
id pubmed-5027112
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-50271122016-09-22 Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study Crespo-Salgado, Janice Vehaskari, V. Matti Stewart, Tyrus Ferris, Michael Zhang, Qiang Wang, Guangdi Blanchard, Eugene E. Taylor, Christopher M. Kallash, Mahmoud Greenbaum, Larry A. Aviles, Diego H. Microbiome Research BACKGROUND: End-stage renal disease (ESRD) is associated with uremia and increased systemic inflammation. Alteration of the intestinal microbiota may facilitate translocation of endotoxins into the systemic circulation leading to inflammation. We hypothesized that children with ESRD have an altered intestinal microbiota and increased serum levels of bacterially derived uremic toxins. METHODS: Four groups of subjects were recruited: peritoneal dialysis (PD), hemodialysis (HD), post-kidney transplant and healthy controls. Stool bacterial composition was assessed by pyrosequencing analysis of 16S rRNA genes. Serum levels of C-reactive protein (CRP), D-lactate, p-cresyl sulfate and indoxyl sulfate were measured. RESULTS: Compared to controls, the relative abundance of Firmicutes (P = 0.0228) and Actinobacteria (P = 0.0040) was decreased in PD patients. The relative abundance of Bacteroidetes was increased in HD patients (P = 0.0462). Compared to HD patients the relative abundance of Proteobacteria (P = 0.0233) was increased in PD patients. At the family level, Enterobacteriaceae was significantly increased in PD patients (P = 0.0020) compared to controls; whereas, Bifidobacteria showed a significant decrease in PD and transplant patients (P = 0.0020) compared to control. Alpha diversity was decreased in PD patients and kidney transplant using both phylogenetic and non-phylogenetic diversity measures (P = 0.0031 and 0.0003, respectively), while beta diversity showed significant separation (R statistic = 0.2656, P = 0.010) between PD patients and controls. ESRD patients had increased serum levels of p-cresyl sulfate and indoxyl sulfate (P < 0.0001 and P < 0.0001, respectively). The data suggests that no significant correlation exists between the alpha diversity of the intestinal microbiota and CRP, D-lactate, or uremic toxins. Oral iron supplementation results in expansion of the phylum Proteobacteria. CONCLUSIONS: Children with ESRD have altered intestinal microbiota and increased bacterially derived serum uremic toxins. BioMed Central 2016-09-17 /pmc/articles/PMC5027112/ /pubmed/27640125 http://dx.doi.org/10.1186/s40168-016-0195-9 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Crespo-Salgado, Janice
Vehaskari, V. Matti
Stewart, Tyrus
Ferris, Michael
Zhang, Qiang
Wang, Guangdi
Blanchard, Eugene E.
Taylor, Christopher M.
Kallash, Mahmoud
Greenbaum, Larry A.
Aviles, Diego H.
Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study
title Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study
title_full Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study
title_fullStr Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study
title_full_unstemmed Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study
title_short Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study
title_sort intestinal microbiota in pediatric patients with end stage renal disease: a midwest pediatric nephrology consortium study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5027112/
https://www.ncbi.nlm.nih.gov/pubmed/27640125
http://dx.doi.org/10.1186/s40168-016-0195-9
work_keys_str_mv AT cresposalgadojanice intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy
AT vehaskarivmatti intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy
AT stewarttyrus intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy
AT ferrismichael intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy
AT zhangqiang intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy
AT wangguangdi intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy
AT blanchardeugenee intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy
AT taylorchristopherm intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy
AT kallashmahmoud intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy
AT greenbaumlarrya intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy
AT avilesdiegoh intestinalmicrobiotainpediatricpatientswithendstagerenaldiseaseamidwestpediatricnephrologyconsortiumstudy